Skip to main content

Clinical Trials for Obesity and Type 2 Diabetes Michigan

Exploring Potential Treatment Options for Obesity & Type 2 Diabetes Mellitus.

Struggling with Obesity & Type 2 Diabetes?

Let’s Find a Better Way Through Research!

Obesity & Type 2 Diabetes Mellitus (T2DM) are two interconnected health conditions that significantly impact millions of adults worldwide. Approximately 1.9 billion people worldwide are overweight, of which 650 million are living with obesity.

Obesity is a major risk factor for T2DM, leading to insulin resistance, increased blood sugar levels, and complications affecting cardiovascular and metabolic health. Managing these conditions effectively requires innovative treatment options, which is where clinical research plays a crucial role.

Revival Research Institute is conducting Clinical Trials for Obesity and Type 2 Diabetes Michigan to explore potential therapies that may improve weight management and blood sugar control. These trials aim to evaluate the efficacy and safety of investigational medications that target weight loss, metabolic function, and glucose regulation.

Are You Eligible for the Study?

To participate in the Type 2 Diabetes & Obesity Study Research Study, you must meet the following eligibility criteria:

  • Adult males or females aged 18-75 years
  • Body Mass Index (BMI) between 27.0 and 50.0 kg/m2
  • Diagnosed with Type 2 Diabetes Mellitus for at least 3 months

*Additional criteria may apply.

Despite the increasing prevalence of obesity & type 2 diabetes mellitus, there are limited effective treatment options. Clinical trials for Obesity and Type 2 Diabetes Michigan are essential in finding new ways to help individuals manage their conditions.

Please provide YOUR contact information only.
Clinical Trials For Obesity and Type 2 Diabetes

About the Clinical Trials for Obesity and Type 2 Diabetes Michigan

This is a Phase 2b, multi-center, randomized, double-blind, placebo-controlled study evaluating an investigational drug, in adults with obesity & type 2 diabetes mellitus.

Key Study Details:

  • Total Study Duration: 36 weeks
  • Screening Period: Up to 4 weeks
  • Treatment Period: 28 weeks
  • Post-Treatment Follow-up: 4 weeks
  • Study Design: Participants will be randomly assigned to receive either an investigational drug or a placebo in a once-weekly subcutaneous injection

Eligible participants will undergo regular study visits, including physical examinations, blood sample collections, and medical assessments to monitor their health and progress. A team of experienced healthcare professionals will oversee every aspect of the study.

*All study procedures and study-related treatments, including the investigational drug, are provided at no cost, and no insurance is required to participate, and participants may receive compensation for time and travel.

*To take the next step, submit the form above, and our research staff will contact you to determine if you qualify for the study. A brief discussion about your health and medical history may be required.

Get Started: What to Expect?

If you are living with obesity and Type 2 Diabetes Mellitus, you may qualify for a paid clinical trial focused on potential treatment options for both conditions. After completing the interest from above, a research team member will contact you for a brief pre-screening to see if you meet the initial eligibility criteria. If you qualify, you will be asked to review and sign an Informed Consent Form (ICF), which explains all study procedures, potential benefits, and risks.

Following your consent, you’ll be invited to a screening visit at our clinical research site. During this initial visit, we will ask questions about your medical history, perform physical exams, and run lab tests to further assess your eligibility. If you meet all study requirements, you will be officially enrolled in the clinical trial.

Our team will ensure you fully understand your role in the study and what to expect throughout the process. You are encouraged to ask any questions before enrolling. Your participation helps advance future treatments for obesity and Type 2 Diabetes Mellitus.

Age

18-75 years of age

Condition

Obesity & Type 2 Diabetes Mellitus

Location

Troy, Michigan

Understanding Obesity & Type 2 Diabetes Mellitus

Obesity and Type 2 Diabetes

Obesity & Type 2 Diabetes Mellitus often go hand in hand, creating significant health risks, including:

  • Increased cardiovascular disease risk
  • Higher likelihood of kidney disease
  • Neuropathy (nerve damage)
  • Vision problems (diabetic retinopathy)
  • Complications in wound healing

Managing these conditions requires a multifaceted approach, including lifestyle changes, medication, and, in some cases, clinical interventions. Participation in Clinical Trials for Obesity and Type 2 Diabetes Michigan can provide access to investigational treatments aimed at improving health outcomes.

Frequently Asked Questions (FAQs)

Frequently Asked Questions (FAQs)

What is obesity & type 2 diabetes mellitus?

Obesity is a medical condition characterized by excessive fat accumulation, leading to adverse health effects. Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder where the body becomes resistant to insulin, leading to high blood sugar levels. The two conditions are closely linked, as obesity is a primary risk factor for T2DM.

What causes obesity & type 2 diabetes mellitus?

Both conditions are influenced by genetics, lifestyle, and environmental factors. Poor diet, lack of exercise, and metabolic imbalances contribute to obesity, while insulin resistance and beta-cell dysfunction lead to T2DM.

How can obesity & type 2 diabetes mellitus be managed?

Several approaches can help manage these conditions, including:

  • Dietary changes: A balanced diet low in processed sugars and unhealthy fats
  • Physical activity: Regular exercise to improve insulin sensitivity and aid weight loss
  • Medications: Prescription drugs for weight management and blood sugar control
  • Clinical trials: Participation in research studies exploring innovative treatments

How long will the clinical trial last?

The Clinical Trials for Obesity and Type 2 Diabetes Michigan will last approximately 36 weeks, including screening, treatment, and follow-up periods. Participants will receive detailed study overviews, including visit schedules and procedures, before enrollment.

Is participation voluntary?

Yes, participation is completely voluntary, and participants may withdraw from the study at any time.

Advancing Treatment for Endocrine Disorders

Managing obesity and T2DM falls under the broader spectrum of treatment for endocrine disorders. Researchers are continuously working on developing medications that improve metabolic function, regulate glucose levels, and assist in weight loss. Participating in Clinical Trials for Obesity and Type 2 Diabetes Michigan provides an opportunity to contribute to medical advancements in treatment for endocrine disorders while potentially accessing innovative therapies before they are widely available.

logo-normal

We are dedicated to advancing medicine & redefining patient care, one clinical trial at a time — with compassion. We are Revival’s Site Network spanning across Michigan, Texas, Nebraska, Georgia, Arizona & Illinois.

Quick Links

Quick Links

Contact Info

  • 28270 Franklin Road, Suite F
    Southfield, MI 48034
  • 248-721-9539
Close Menu